Yep. Even with "old drugs" the new programs using those give significantly better chances than with the old programs. Year of data collecting sure have given results.
I had testicular cancer in 2006 in Chile. I was a teenager so I went with the public system (AUGE back then). My parents friends were giving the condolences for my soon to occur death. The doctors had a laugh as in the last 10 years (by then) my chances of dying of it became basically nil.
Last year we hired a new guy at $JOB that 1 week after being hired was diagnosed with testicular cancer too. He really thought he was gonna die. He was at stage 4 (which is a highly zone specific metric). Last time I saw him he is still coding and more bald. It was more difficult to sort payments than the treatment as he is in the US.
Most testicular cancer is now reliably curable by harsh but effective chemotherapy. Mission accomplished? Not quite. Curative drugs such as cisplatin are scarce. Their patents are long-expired, so they're less profitable to manufacture, so manufacturers don't manufacture them. Hooray for the free market.
I had testicular cancer in 2006 in Chile. I was a teenager so I went with the public system (AUGE back then). My parents friends were giving the condolences for my soon to occur death. The doctors had a laugh as in the last 10 years (by then) my chances of dying of it became basically nil.
Last year we hired a new guy at $JOB that 1 week after being hired was diagnosed with testicular cancer too. He really thought he was gonna die. He was at stage 4 (which is a highly zone specific metric). Last time I saw him he is still coding and more bald. It was more difficult to sort payments than the treatment as he is in the US.